Skip to main content

Advertisement

Log in

Should Pelvic and Para-aortic Lymphadenectomy Be Different Depending on Histological Subtype in Epithelial Ovarian Cancer?

  • Gynecologic Oncology
  • Original Paper
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The aim of this study was to determine the influence of the different histological subtypes (serous versus non-serous) on the location of nodal metastases in patients undergoing pelvic and para-aortic lymphadenectomies during the initial management of epithelial ovarian tumors.

Methods

We carried out a retrospective analysis of data concerning patients fulfilling the following inclusion criteria: (1) an epithelial ovarian tumor; (2) a complete pelvic and bilateral para-aortic lymphadenectomy up to the level of the left renal vein; (3) surgical procedures including lymphadenectomies performed before adjuvant chemotherapy; and (4) a description of the distribution of positive nodes removed between pelvic and para-aortic areas. Patients were classified into two groups according to the histological subtypes: serous (group 1) and non-serous (group 2) tumors.

Results

Of patients treated between 1989 and 2005, 148 fulfilled the inclusion criteria: 73 had a serous tumor and 75 a non-serous tumor. Positive nodes were observed in 70 (47%) patients—47 (64%) in group 1 and 23 (31%) in group 2 (P < 0.05). But the distribution of involved nodes between pelvic and para-aortic areas in patients with positive nodes was not statistically different between the two groups. In both groups, the most common site for positive nodes in the para-aortic area was the left para-aortic group: 74% in group 1 and 61% in group 2 (NS).

Conclusions

This series suggests that the histological subtype has no impact on the distribution of positive nodes in pelvic and para-aortic areas in patients with epithelial ovarian tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Maggioni A, Benedetti Panici PL, Dell’Anna T, et al. Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer 2006; 95:699–704

    Article  PubMed  CAS  Google Scholar 

  2. Benedetti-Panici P, Maggioni A, Hacker N, et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst 2005; 97:560–6

    Article  Google Scholar 

  3. Wu PC, Qu JY, Lang JH, Huang RL, Tang MY, Lian LJ. Lymph node metastasis of ovarian cancer: a preliminary survey of 74 cases of lymphadenectomy. Am J Obstet Gynecol 1986; 155:1103–8

    PubMed  CAS  Google Scholar 

  4. Di Re F, Fontanelli R, Raspagliesi F, Di Re E. Pelvic and para-aortic lymphadenectomy in cancer of the ovary. Baillieres Clin Obstet Gynaecol 1989; 3:131–42

    Article  PubMed  CAS  Google Scholar 

  5. Benedetti-Panici P, Greggi S, et al. Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer. Gynecol Oncol 1993; 51:150–4

    Article  PubMed  CAS  Google Scholar 

  6. Di Re F, Baiocchi G. Value of lymph node assessment in ovarian cancer : Status of the art at the end of second millenium. Int J Gynecol Cancer 2000; 6:435–42

    Article  Google Scholar 

  7. Burghardt E, Pickel H, Lahousen M, Stettner H. Pelvic lymphadenectomy in operative treatment of ovarian cancer. Am J Obstet Gynecol 1986; 155:315–9

    PubMed  CAS  Google Scholar 

  8. Tsumura N, Sakuragi N, Hareyama H, et al. Distribution pattern and risk factors of pelvic and para-aortic lymph node metastasis in epithelial ovarian carcinoma. Int J Cancer 1998; 23:526–30

    Article  Google Scholar 

  9. Morice P, Joulie F, Camatte S, et al. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and para-aortic lymphadenectomies and surgical implications. J Am Coll Surg 2003; 197:198–205

    Article  PubMed  Google Scholar 

  10. Meier WJ. Lymphadenectomy in stage I ovarian cancer. Proc ASCO 2000; 19:1541

    Google Scholar 

  11. Takeshima N, Hirai Y, Umayahara K, Fujiwara K, Takizawa, Hasumi K. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors. Gynecol Oncol 2005; 99:427–31

  12. Chambers SK. Systematic lymphadenectomy in advanced epithelial ovarian cancer: two decades of uncertainty resolved. J Natl Cancer Inst 2005; 97:548–9

    PubMed  Google Scholar 

  13. Morice P, Pautier P, Lhommé C, Castaigne D. Systematic lymphadenectomy in advanced stage ovarian cancer: is discussion closed? J Natl Cancer Inst 2005; 97:1620–1

    PubMed  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge Lorna Saint Ange for editing this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philippe Morice MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roger, N., Zafrani, Y., Uzan, C. et al. Should Pelvic and Para-aortic Lymphadenectomy Be Different Depending on Histological Subtype in Epithelial Ovarian Cancer?. Ann Surg Oncol 15, 333–338 (2008). https://doi.org/10.1245/s10434-007-9639-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-007-9639-6

Keywords

Navigation